Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Tofacitinib may effectively treat folliculitis decalvans.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Setipiprant did not significantly improve hair growth in men with hair loss.

Upadacitinib may cause hair loss.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Targeted cancer therapies often cause serious skin problems that need careful management.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.